864293-00-5 Usage
Uses
Used in Pharmaceutical Industry:
2,4-dihydroxyquinazoline-7-carboxylic acid is used as a key intermediate for the synthesis of various pharmaceuticals and biologically active compounds. Its unique structural properties and pharmacological activities make it a promising candidate for the development of antitumor and antibacterial agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,4-dihydroxyquinazoline-7-carboxylic acid is utilized for its potential applications in drug discovery. Its structural properties and pharmacological activities allow researchers to explore its use in the design and synthesis of novel therapeutic agents.
Used in Drug Discovery:
2,4-dihydroxyquinazoline-7-carboxylic acid is employed in drug discovery processes to identify and develop new therapeutic agents with potential antitumor and antibacterial properties. Its unique structural features and pharmacological activities provide a foundation for the development of innovative drugs to address various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 864293-00-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,2,9 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 864293-00:
(8*8)+(7*6)+(6*4)+(5*2)+(4*9)+(3*3)+(2*0)+(1*0)=185
185 % 10 = 5
So 864293-00-5 is a valid CAS Registry Number.
864293-00-5Relevant academic research and scientific papers
A facile and convenient approach for the one-pot synthesis of 2,4(1H,3H)-quinazolinediones
Sharafi-Kolkeshvandi, Mahnaz,Nikpour, Farzad
experimental part, p. 431 - 433 (2012/06/18)
A fast and efficient method is described for the one-pot synthesis of 2,4(1H,3H)-quinazolinediones by cyclization reaction of anthranilic acid derivatives with potassium cyanate and acetic acid in PEG. Good to high yields of the products obtain in short reaction times with simple work-up.
SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
-
Page/Page column 85, (2012/04/23)
This invention provides compounds of formula (I): wherein R1a, R1b, Ra, R2a, R2b, R1, and X have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS
-
Page/Page column 136, (2008/06/13)
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
